Back to Journals » OncoTargets and Therapy » Volume 4 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/23/cope/thumb_100_1000_100.jpg)
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6517)
- Volume 17, 2024 (79)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 4, 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
Deshpande H, Marler V, Sosa JA
OncoTargets and Therapy 2011, 4:209-215
Published Date: 9 December 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institution
Lin CZ, Jin KT, Lan HR, Teng LS, Lin JJ, Chen WB
OncoTargets and Therapy 2011, 4:203-208
Published Date: 30 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies
Kobayakawa M, Kojima Y
OncoTargets and Therapy 2011, 4:193-201
Published Date: 15 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
Muñoz-Couselo E, Pérez-García J, Cortés J
OncoTargets and Therapy 2011, 4:185-192
Published Date: 14 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted treatment for chronic lymphocytic leukemia
Masood A, Sher T, Paulus A, Miller KC, Chitta KS, Chanan-Khan A
OncoTargets and Therapy 2011, 4:169-183
Published Date: 4 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia
Hoeksema KA, Jayanthan A, Cooper T, Gore L, Trippett T, Boklan J, Arceci RJ, Narendran A
OncoTargets and Therapy 2011, 4:149-168
Published Date: 5 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents
Khan MK, Khan N, Almasan A, Macklis R
OncoTargets and Therapy 2011, 4:137-148
Published Date: 9 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
Yamamoto Y, Kawano I, Iwase H
OncoTargets and Therapy 2011, 4:123-136
Published Date: 18 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine
Ahmad EI, Gawish HH, Al Azizi NMA, Elhefni AM
OncoTargets and Therapy 2011, 4:115-121
Published Date: 15 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current therapeutic strategies for invasive and metastatic bladder cancer
Vishnu P, Mathew J, Tan WW
OncoTargets and Therapy 2011, 4:97-113
Published Date: 11 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments
Gupta SG, Carballido ES, Fishman M
OncoTargets and Therapy 2011, 4:79-96
Published Date: 29 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells
Phuc PV, Nhan PLC, Nhung TH, Tam NT, Hoang NM, Tue VG, Thuy DT, Ngoc PK
OncoTargets and Therapy 2011, 4:71-78
Published Date: 21 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasis
Sorenson BS, Banton KL, Augustin LB, Leonard AS, Saltzman DA
OncoTargets and Therapy 2011, 4:59-69
Published Date: 30 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
Ballas MS, Chachoua A
OncoTargets and Therapy 2011, 4:43-58
Published Date: 30 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An update on TroVax® for the treatment of progressive castration-resistant prostate cancer
Abern M, Kaufman HL, Latchamsetty K
OncoTargets and Therapy 2011, 4:33-41
Published Date: 24 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets
Kounnis V, Ioachim E, Svoboda M, Tzakos A, Sainis I, Thalhammer T, Steiner G, Briasoulis E
OncoTargets and Therapy 2011, 4:27-32
Published Date: 8 April 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New developments in the treatment of metastatic gastric cancer: focus on trastuzumab
Rose JS, Bekaii-Saab TS
OncoTargets and Therapy 2011, 4:21-26
Published Date: 24 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis
William C Dooley, James C Wurzer, Mohamed Megahy, et al
OncoTargets and Therapy 2011, 4:13-20
Published Date: 12 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
Carmen Criscitiello, Debora Fumagalli, Kamal S Saini, et al
OncoTargets and Therapy 2011, 4:1-11
Published Date: 17 December 2010